Connect with us

Business

AstraZeneca and Johnson & Johnson to resume COVID-19 vaccine trials as U.S. daily cases top 71,000 – CBS News

On Friday, both AstraZeneca and Johnson & Johnson announced their coronavirus vaccine trials are set to resume in the U.S. after hitting pause when volunteers became…

Published

on

post featured image
ADVERTISEMENT

On Friday, both AstraZeneca and Johnson & Johnson announced that their coronavirus vaccine trials are set to resume in the U.S. after hitting pause when volunteers became sick. The Food and Drug Administration gave the green light after investigations found no link between those cases and the vaccine.
The announcement comes as the U.S. recorded more than 71,000 coronavirus cases on Thursday, which is the highest single-day increase since July, according to figures from Johns Hopkins University….

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Oxford, WHO scientists say more data needed on AstraZeneca’s Covid vaccine trials – CNBC
post featured image
Bitcoin whale clusters show these are the strong support levels – Cointelegraph
post featured image
Michigan reports 17,162 new cases of COVID-19 over 2-day period, 172 deaths – WXYZ